Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05429268 |
|---|---|
| Brief Title: | Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND) (firmMIND) |
| First Submitted : | June 17, 2022 |
| First Submitted that Met QC Criteria : | June 17, 2022 |
| First Posted : | June 23, 2022 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |